Food And Drug Administration

Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
35 Cannabis Innovators To Watch In 2024: Leaders Shaping The Green Revolution
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
35 Cannabis Innovators To Watch In 2024: Leaders Shaping The Green Revolution
EXCLUSIVE: FDA Advisors Say Regulatory Certainty Needed For Cannabis Market
Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling

Food And Drug Administration Recent News

Supreme Court Allows Abortion Pill To Stay On The Market
The U.S. Supreme Court has halted a Texas judge's restrictions on a widely used abortion pill, allowing it to remain on the market. 
Judge Halts FDA Approval Of Abortion Pill, Biden Administration Vows To Fight
A U.S. judge in Texas has suspended the government's decades-old approval of the abortion pill mifepristone, which terminates a pregnancy within the first 10 weeks.
Hot Hemp Synthetic Cannabinoids: A Threat To Utah's Medical Cannabis Industry?
The medical cannabis industry in Utah is confusing since synthetic cannabinoid-laden products appeared in naturally abundant amounts on dispensary shelves. According to the FDA, CBD is synthesized from delta-8, THC and a variety of other cannabinoids that could pose "serious health risks."
What Is The Role Of The FDA In Measures Taken By Hawaii Officials Against A CBD Company?
The Hawaii Department of Health (DOH) and Hawaii Department of Public Safety (PSD) conducted operations to execute search warrants and to embargo products at several retail stores including a CBD dispensary in Honolulu, reported
Could Biden Extinguish Tobacco Stocks With This Regulation?
The U.S. government could be speeding up a plan to ban menthol cigarettes, according to a new report. Here’s the new timeline and two stocks that could be affected.
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned.
Texas Judge Upholds Delta-8 THC Ban, New Hearing Expected In Nov.
As more and more states embrace the cannabis plant in its “full form,” some still challenge the legality of hemp-based products.
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Year-end reviews by the Food and Drug Administration produced mostly positive outcomes, with most therapies passing the regulatory hurdle without any hiccups.
Gilead To Explore Trodelvy Drug Against Different Cancers After $21B Merger With Immunomedics
After initial reports emerged on Saturday about a potential acquisition deal, Gilead Sciences Inc (NASDAQ: GILD) confirmed that it's set to purchase 
Pfizer Seeks FDA Nod To Expand Late-Stage COVID-19 Vaccine Trial
Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Saturday they are seeking the United States Food and Drug Administration approval to expand the late-stage clinical trial of their COVID-19 vacc
Aimmune Shares Surge 170% As Nestle Set To Acquire Company At $2.6B Enterprise Value
Nestle S.A. (OTC: NSRGY) subsidiary Nestle Health Sciences (NHSc) is aquiring biopharma company Aimmune Therapeutics, Inc.
Abbott Gets FDA Emergency Use Approval For $5 Rapid COVID-19 Test
The United States Food and Drug Administration granted emergency use authorization to a 15-minute COVID-19 test produced by Abbott Laboratories (NYSE: ABT) on Wednesday.
Government Outlines Plan For Importation Of Cheaper Drugs From Canada
FDA Schedules First Public Hearing On CBD, Sends Warning Letters To 3 Companies
'An Incredible Signal': 4 Experts Weigh In On Positive FDA Panel Vote For GW Pharma's Epidiolex
The Current State Of The Breast Cancer Treatment Space
FDA Targets LifeVantage, 13 Other Companies Selling Illegal Cancer Treatments
Abbott Takes Action On FDA Warning Letter
Exclusive: Progenics CEO Talks Regulatory Climate, Positive Trials For Ultra-Orphan Azedra
Sarepta Therapeutics Surges 20% On No News
Salesforce Touts Benefits Of New $100 Million Contract From US Government Agency
Here's Why Eagle Pharmaceuticals Fell 7%